Literature DB >> 27924991

Improving cell penetration of helical peptides stabilized by N-terminal crosslinked aspartic acids.

Hui Zhao1, Yanhong Jiang1, Yuan Tian2, Dan Yang1, Xuan Qin1, Zigang Li1.   

Abstract

Cell penetration and nucleus translocation efficiency are important for the cellular activities of peptide therapeutics. For helical peptides stabilized by N-terminal crosslinked aspartic acid, correlations between their penetration efficiency/nucleus translocation and physicochemical properties were studied. An increase in hydrophobicity and isoelectric point will promote cellular uptake and nucleus translocation of stabilized helices.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27924991     DOI: 10.1039/c6ob02501c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

Review 2.  Emerging Methods and Design Principles for Cell-Penetrant Peptides.

Authors:  Leila Peraro; Joshua A Kritzer
Journal:  Angew Chem Int Ed Engl       Date:  2018-08-17       Impact factor: 15.336

3.  Achieving enhanced cell penetration of short conformationally constrained peptides through amphiphilicity tuning.

Authors:  Yuan Tian; Xiangze Zeng; Jingxu Li; Yanhong Jiang; Hui Zhao; Dongyuan Wang; Xuhui Huang; Zigang Li
Journal:  Chem Sci       Date:  2017-09-13       Impact factor: 9.825

4.  Metal-Dependent DNA Recognition and Cell Internalization of Designed, Basic Peptides.

Authors:  Soraya Learte-Aymamí; Natalia Curado; Jéssica Rodríguez; M Eugenio Vázquez; José L Mascareñas
Journal:  J Am Chem Soc       Date:  2017-11-01       Impact factor: 15.419

Review 5.  Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity.

Authors:  Daniela Kalafatovic; Ernest Giralt
Journal:  Molecules       Date:  2017-11-08       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.